|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.094
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.078
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.074
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.069
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.066
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.064
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.061
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.057
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.057
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.056
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.055
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.055
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.053
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.053
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.052
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.048
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.047
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.045
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.044
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.043
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.042
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.040
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.038
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.038
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.038
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.038
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.038
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.037
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.037
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.037
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.036
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.036
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.036
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.036
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.035
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.035
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.035
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.034
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.034
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.033
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.032
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.032
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.031
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.031
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.031
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.031
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.031
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.030
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.030
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.030
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.029
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.029
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.029
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.028
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.028
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.028
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.027
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.027
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.026
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.026
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.026
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.026
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.026
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.025
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.025
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.025
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.025
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.024
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.024
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.024
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.024
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.023
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.023
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.023
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.023
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.023
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.023
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.023
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.023
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.023
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.022
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.022
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.022
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.022
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.022
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.021
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.021
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.021
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.021
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.021
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.020
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.020
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.020
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.020
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.020
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.020
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.020
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.020
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.020
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.020
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.019
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.019
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.019
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.019
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.019
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.019
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.019
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.019
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.019
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.018
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.018
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.018
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.018
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.018
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.018
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.018
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.018
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.018
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.018
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.017
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.017
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.017
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.017
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.017
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.017
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.017
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.017
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.017
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.017
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.017
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.017
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.017
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.017
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.016
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.016
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.016
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.016
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.016
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.016
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.016
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.016
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.016
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.016
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.016
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.016
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.016
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.016
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.016
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.016
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.016
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.016
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.016
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.015
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.015
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.015
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.015
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.015
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.015
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.015
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.015
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.015
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.015
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.015
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.015
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.015
|
|
|
|
positive regulation of transcription from rna polymerase i promoter
|
GO:0045943 |
3 |
0.015
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.014
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.014
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.014
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.014
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.014
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.014
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.014
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.014
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.014
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.014
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.014
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.014
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.014
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.014
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.014
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.013
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.013
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.013
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.013
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.013
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.013
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.013
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.013
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.013
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.013
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.013
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.013
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.013
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.013
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.013
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.013
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.013
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.013
|
|
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
4 |
0.013
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.013
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.013
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.013
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.013
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.012
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.012
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.012
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.012
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.012
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.012
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.012
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.012
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.012
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.012
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.012
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.012
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.012
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.012
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.012
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.012
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.012
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.012
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.012
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.012
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.012
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.012
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.012
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.012
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.012
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.012
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.012
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.012
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.012
|
|
|
|
negative regulation of cell proliferation involved in contact inhibition
|
GO:0060244 |
3 |
0.012
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.011
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.011
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.011
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.011
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.011
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.011
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.011
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.011
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.011
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.011
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.011
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.011
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.011
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.011
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.011
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.011
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.011
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.011
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.011
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.011
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.011
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.011
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.011
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.011
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.011
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.011
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.011
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.011
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.011
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.011
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.011
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.011
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.011
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.011
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.011
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.011
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.011
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.011
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.011
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.011
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.011
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.011
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.011
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.011
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.011
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.011
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.011
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.011
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.011
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.011
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.011
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.011
|
|
|
|
regulation of macrophage migration inhibitory factor signaling pathway
|
GO:2000446 |
1 |
0.011
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.011
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.010
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.010
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.010
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.010
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.010
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.010
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.010
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.010
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.010
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.010
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.010
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.010
|
|